Table 2.
Univariate and multivariate analysis of the variables significantly associated with severe GvHD.
| aGvHD | n with outcome/n with variant | n with outcome/n without variant | Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|---|---|---|
| ODDS ratio | CI 95% | P | ODDS ratio | CI 95% | P | ||||
| IL10-1082GG DNR |
II–IV | 12/16 (75.0%) | 33/85 (38.8%) | 3.77 | 1.33–12.0 | 0.012 | 4.50 | 1.45–16.58 | 0.008 |
| III-IV | 4/16 (25.0%) | 7/85 (8.2%) | 4.21 | 1.17–14.65 | 0.029 | 5.15 | 0.95–30.15 | 0.057 | |
|
| |||||||||
| FAS-670CC + CT DNR |
II–IV | 38/74 (52.3%) | 7/27 (25.9%) | 2.81 | 1.12–7.65 | 0.027 | 2.90 | 1.11–8.35 | 0.029 |
| III-IV | 11/74 (14.9%) | 0/27 (0%) | 9.81 | 1.20–1274 | 0.029 | ns | |||
|
| |||||||||
| TLR4-3612TT DNR |
III-IV | 11/51 (21.6%) | 2/56 (3.4%) | 6.82 | 1.88–36.47 | 0.002 | 12.86 | 2.47–138.8 | 0.001 |
|
| |||||||||
| IL18-607TT + TG PT |
II–IV | 39/77 (50.6%) | 7/30 (23.3%) | 3.08 | 1.25–8.31 | 0.014 | ns | ||
|
| |||||||||
| SSC | III-IV | 3.83 | 1.25–8.51 | 0.003 | 6.20 | 1.40–32.31 | 0.016 | ||
DNR: donor; PT: patient; SSC: source of stem cells; ns: not significant.